Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Studies of gene regulation by oxygen have revealed novel signal pathways that regulate the hypoxia-inducible factor (HIF) transcriptional system through post-translational hydroxylation of specific prolyl and asparaginyl residues in HIF-alpha subunits. These oxygen-sensitive modifications are catalyzed by members of the 2-oxoglutarate (2-OG) dioxygenase family (PHD1, PHD2, PHD3, and FIH-1), raising an important question regarding the extent of involvement of these and other enzymes of the same family in directing the global changes in gene expression that are induced by hypoxia. To address this, we compared patterns of gene expression induced by hypoxia and by a nonspecific 2-OG-dependent dioxygenase inhibitor, dimethyloxalylglycine (DMOG), among a set of 22,000 transcripts, by microarray analysis of MCF7 cells. By using short interfering RNA-based suppression of HIF-alpha subunits, we also compared responses that were dependent on, or independent of, the HIF system. Results revealed striking concordance between patterns of gene expression induced by hypoxia and by DMOG, indicating the central involvement of 2-OG-dependent dioxygenases in oxygen-regulated gene expression. Many of these responses were suppressed by short interfering RNAs directed against HIF-1alpha and HIF-2alpha, with HIF-1alpha suppression manifesting substantially greater effects than HIF-2alpha suppression, supporting the importance of HIF pathways. Nevertheless, the definition of genes regulated by both hypoxia and DMOG, but not HIF, distinguished other pathways most likely involving the action of 2-OG-dependent dioxygenases on non-HIF substrates.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HIF-1 is a transcription factor that regulates the expression of hundreds of genes in response to hypoxia, including VEGF, which encodes vascular endothelial growth factor, a key regulator of angiogen- esis; GLUT1, which encodes glucose transporter 1; and HK1 and HK2, which encode hexokinase, the first enzyme of the glycolytic pathway (4, 5).”
From Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth (2008) · cites this paper as [5]
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Pfaffl, M. W. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.e36 · Cited by 7,376
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Self-citationThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., & Nishizuka, Y. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34459-4 · Cited by 4,725
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationA conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Self-citation
Research works printed but not linked: 3
- Alarcon, 1999, Cancer Res., 59, 6046
- Sowter, 2003, Cancer Res., 63, 6130
- Charpentier, 2000, Cancer Res., 60, 5977
Cited by
Items 101–200 of 470
Molecular Responses to Hypoxia-Inducible Factor 1α and Beyond
Brocato, J., Chervona, Y., & Costa, M. (2014) · Molecular Pharmacology · doi:10.1124/mol.113.089623 · Cited by 128
“factors that mediate cellular responses to reduced oxygen availability through transcriptional activation of a multitude of genes that encode proteins needed for tissue O2 delivery and energy metabolism (Elvidge et al., 2006; Manalo et al., 2005).”
BackgroundThe human oxygen sensing machinery and its manipulation
Chowdhury, R., Hardy, A., & Schofield, C. J. (2008) · Chemical Society Reviews · doi:10.1039/b701676j · Cited by 109
Chan, M. C., Ilott, N. E., Schödel, J., Sims, D., Tumber, A., Lippl, K., Mole, D. R., Pugh, C. W., Ratcliffe, P. J., Ponting, C. P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.749291 · Cited by 110
Self-citationRegulation of intracellular pH in cancer cell lines under normoxia and hypoxia
Hulikova, A., Harris, A. L., Vaughan‐Jones, R. D., & Swietach, P. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24221 · Cited by 105
“This drugmimics a vastmajority of hypoxia-triggered genomic responses, including HIF-mediated responses (Elvidge et al., 2006).”
BackgroundGremlin Plays a Key Role in the Pathogenesis of Pulmonary Hypertension
Cahill, E., Costello, C. M., Rowan, S. C., Harkin, S., Howell, K., Leonard, M. O., Southwood, M. R., Cummins, E. P., Fitzpatrick, S. F., Taylor, C. T., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.038125 · Cited by 112
Li, Y., Padmanabha, D., Gentile, L. B., Dumur, C. I., Beckstead, R. B., & Baker, K. D. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003230 · Cited by 110
Massive transcriptional start site analysis of human genes in hypoxia cells
Tsuchihara, K., Suzuki, Y., Wakaguri, H., Irie, T., Tanimoto, K., Hashimoto, S., Matsushima, K., Mizushima‐Sugano, J., Yamashita, R., Nakai, K., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp066 · Cited by 118
“gov/geo/) [a: GDS2758-61 (7); b: GDS1209 (8); c: GDS2018 (6); d: GDS1779 (9), for the GEO accession numbers and references, respectively].”
ResultInfluentialThe Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer
Zhang, C., Liu, J., Wang, J., Zhang, T., Xu, D., Hu, W., & Feng, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.648808 · Cited by 95
Yeh, S.-H., Ou, L.-C., Gean, P., Hung, J., & Chang, W. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00443.x · Cited by 106
“Recent studies using microarrays revealed that HIF-1a overexpression and hypoxia upregulated various genes, including those involved in apoptosis (eg, Nix) and oncogenes (eg, VEGF) (10, 31).”
BackgroundYoo, S., Takikawa, S., Geraghty, P., Argmann, C., Campbell, J., Lin, L., Huang, T., Tu, Z., Feronjy, R., Spira, A., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1004898 · Cited by 105
Aro, E., Khatri, R., Gerard-O'Riley, R., Mangiavini, L., Myllyharju, J., & Schipani, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.352872 · Cited by 92
Prolyl Hydroxylase Domain Inhibitors: A Route to HIF Activation and Neuroprotection
Harten, S. K., Ashcroft, M., & Maxwell, P. H. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2870 · Cited by 99
Pichiule, P., Chavez, J. C., Schmidt, A. M., & Vannucci, S. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706407200 · Cited by 112
Bobarykina, A. Y., Minchenko, D. O., Opentanova, I. L., Moenner, M., Caro, J., Esumi, H., & Minchenko, О. H. (2006) · Acta Biochimica Polonica · doi:10.18388/abp.2006_3308 · Cited by 111
Regulation of growth differentiation factor 15 expression by intracellular iron
Lakhal, S., Talbot, N. P., Crosby, A., Stoepker, C., Townsend, A. R. M., Robbins, P. A., Pugh, C. W., Ratcliffe, P. J., & Mole, D. R. (2009) · Blood · doi:10.1182/blood-2008-07-170431 · Cited by 95
Self-citationUltra high-risk PFA ependymoma is characterized by loss of chromosome 6q
Baroni, L., Sundaresan, L., Heled, A., Coltin, H., Pajtler, K. W., Lin, T., Merchant, T. E., McLendon, R. E., Faria, C. C., Buntine, M. K., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab034 · Cited by 94
Hypoxia. Regulation of NFκB signalling during inflammation: the role of hydroxylases
Oliver, K. M., Taylor, C. T., & Cummins, E. P. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2575 · Cited by 92
“While one subset of HIF target genes actively maintains the epithelial barrier as discussed previously, another subset of HIF-1-dependent proangiogenic genes may also be activated.”
InfluentialIncreased prevalence of EPAS1 variant in cattle with high-altitude pulmonary hypertension
Newman, J. H., Holt, T. N., Cogan, J. D., Womack, B., Phillips, J. A., Li, C., Kendall, Z., Stenmark, K. R., Thomas, M., Brown, R. D., et al. (2015) · Nature Communications · doi:10.1038/ncomms7863 · Cited by 118
HIF-1-Dependent Induction of Jumonji Domain-Containing Protein (JMJD) 3 under Hypoxic Conditions
Lee, H.-Y., Choi, K., Oh, H., Park, Y.-K., & Park, H. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.2250 · Cited by 87
“More than 500 genes, including vascular endothelial growth factor (VEGF), erythropoietin (EPO), phosphoglycerate kinase-1 (PGK-1), glucose transporter-1 (glut-1), and BCL-2⁄adenovirus E1B 19 kDa interacting protein 3 (Bnip3) are induced under hypoxia in MCF7 cells (Elvidge et al., 2006).”
BackgroundREST is a hypoxia-responsive transcriptional repressor
Cavadas, M. A. S., Mesnieres, M., Crifo, B., Manresa, M. C., Selfridge, A. C., Keogh, C. E., Fabian, Z., Scholz, C. C., Nolan, K. A., Rocha, L. M. A., et al. (2016) · Scientific Reports · doi:10.1038/srep31355 · Cited by 79
Hypoxia-Inducible Factor-1α: The Master Regulator of Endothelial Cell Senescence in Vascular Aging
Alique, M., Sánchez-López, E., Bodega, G., Giannarelli, C., Carracedo, J., & Ramírez, R. (2020) · Cells · doi:10.3390/cells9010195 · Cited by 83
“Further, more than one hundred genes have been identified to be governed by mammalian HIF during O2 deprivation [42,43].”
BackgroundGrampp, S., Platt, J. L., Lauer, V., Salama, R., Kranz, F., Neumann, V. K., Wach, S., Stöhr, C., Hartmann, A., Eckardt, K.-U., et al. (2016) · Nature Communications · doi:10.1038/ncomms13183 · Cited by 84
Self-citationMartens, L. K., Kirschner, K. M., Warnecke, C., & Scholz, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609857200 · Cited by 86
Dysregulated glycolysis as an oncogenic event
Mikawa, T., LLeonart, M. E., Takaori‐Kondo, A., Inagaki, N., Yokode, M., & Kondoh, H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1840-3 · Cited by 89
Zhong, Z., Ramshesh, V. K., Rehman, H., Currin, R. T., Sridharan, V., Theruvath, T. P., Kim, I., Wright, G. L., & Lemasters, J. J. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90287.2008 · Cited by 84
“In addition to HIF-1 , PHDs also directly hydroxylate other targets to effect HIF-1 -independent cellular changes (8, 9, 28).”
BackgroundMITF controls the TCA cycle to modulate the melanoma hypoxia response
Louphrasitthiphol, P., Ledaki, I., Chauhan, J. S., Falletta, P., Siddaway, R., Buffa, F. M., Mole, D. R., Soga, T., & Goding, C. R. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12802 · Cited by 83
“We therefore analyzed the TCGA melanoma cohort for correlations with the previously published Elvidge hypoxia gene expression signature comprising 171 genes that are up‐regulated in response to hypoxia (Elvidge et al., 2006).”
MethodStiehl, D. P., Bordoli, M. R., Abreu‐Rodríguez, I., Wollenick, K., Schraml, P., Gradin, K., Poellinger, L., Kristiansen, G., & Wenger, R. H. (2011) · Oncogene · doi:10.1038/onc.2011.417 · Cited by 86
“The temporal gene expression patterns of 34 known HIF target genes (Aprelikova et al., 2006; Elvidge et al., 2006) were analyzed for HIF-1 and HIF-2 dependency by quantitative PCR in cells exposed to 1% oxygen for 4–72 h.”
MethodREST mediates resolution of HIF-dependent gene expression in prolonged hypoxia
Cavadas, M. A. S., Mesnieres, M., Crifò, B., Manresa, M. C., Selfridge, A. C., Scholz, C. C., Cummins, E. P., Cheong, A., & Taylor, C. T. (2015) · Scientific Reports · doi:10.1038/srep17851 · Cited by 89
York, E. M., Zhang, J., Choi, H. B., & MacVicar, B. A. (2021) · Glia · doi:10.1002/glia.23913 · Cited by 78
“To further confirm our proposed pathway, the involvement of HIF-1α in LTP impairment was tested by applying dimethyloxaloylglycine (DMOG) to acute slices in order to stabilize HIF-1α (Elvidge et al., 2006; Mills et al., 2016).”
MethodZhou, J., Zhang, S., Xue, J., Avery, J., Wu, J., Lind, S. E., & Ding, W.-Q. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.367367 · Cited by 77
Ameri, K., Hammond, E. M., Culmsee, C., Raida, M., Katschinski, D. M., Wenger, R. H., Wagner, E., Davis, R. J., Hai, T., Denko, N. C., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209781 · Cited by 84
“To determine whether the effects of DFO were through its ability to inhibit the PHDs, we tested another mechanistically distinct PHD inhibitor dioxygenase inhibitor dimethyloxalylglycine (DMOG) for its ability to induce ATF3.”
BackgroundInfluentialToustrup, K., Sørensen, B. S., Alsner, J., & Overgaard, J. (2012) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2011.12.006 · Cited by 86
Kunze, R., Zhou, W., Veltkamp, R. C., Wielockx, B., Breier, G., & Marti, H. H. (2012) · Stroke · doi:10.1161/strokeaha.112.669598 · Cited by 83
Induction of long noncoding RNA MALAT1 in hypoxic mice
Wenger, R. H., Lelli, A., Nolan, K., Santambrogio, S., Marti, H. H., Hoogewijs, D., Frew, I. J., Goncalves, A. F., Schönenberger, M. J., & Guinot, A. (2015) · Hypoxia · doi:10.2147/hp.s90555 · Cited by 78
D’Anna, F., Dyck, L. V., Xiong, J., Zhao, H., Berrens, R. V., Qian, J., Bieniasz-Krzywiec, P., Chandra, V., Schoonjans, L., Matthews, J. B., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02087-z · Cited by 78
“Pharmacological activation of HIF using dimethyloxalylglycine (DMOG), a broad-spectrum inhibitor of 2oxoglutarate-dependent hydroxylases [31], affected cryptic transcripts similar to (See figure on previous page.”
BackgroundCobalt stimulates HIF-1-dependent but inhibits HIF-2-dependent gene expression in liver cancer cells
Befani, C., Mylonis, I., Gkotinakou, I.-M., Georgoulias, P., Hu, C.-J., Simos, G., & Liakos, P. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.07.025 · Cited by 70
“SOD2, a HIF-2α specific promoter, is activated by hypoxia, DFO and DMOG but not by cobalt in Huh7 cells.”
InfluentialThe Role of Hypoxia-Inducible Factor-1 Alpha in Renal Disease
Liu, H., Li, Y., & Xiong, J. (2022) · Molecules · doi:10.3390/molecules27217318 · Cited by 83
“Functional evidence that hypoxia-inducible transcription factors are important for clear cell renal cancer HIF-1α and HIF-2α subunits display distinct but overlapping target gene repertoires [62,63].”
BackgroundPietras, A., von Stedingk, K., Lindgren, D., Påhlman, S., & Axelson, H. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0508 · Cited by 71
Deng, A., Arndt, M. A., Satriano, J. A., Singh, P., Rieg, T., Thomson, S. C., Tang, T., & Blantz, R. C. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00153.2010 · Cited by 77
Extracellular matrix genes as hypoxia-inducible targets
Myllyharju, J., & Schipani, E. (2010) · Cell and Tissue Research · doi:10.1007/s00441-009-0841-7 · Cited by 69
“…and degradation of extracellular matrix are also regulated by HIF (Denko et al. 2003; Hofbauer et al. 2003; Wang et al. 2005; Chi et al. 2006; Elvidge et al. 2006; Erler et al. 2006; Pollard et al. 2008), and hypoxia is thus likely to regulate extracellular matrix homeostasis directly…”
InfluentialBaek, J. H., Liu, Y. V., McDonald, K. R., Wesley, J. B., Zhang, H., & Semenza, G. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705627200 · Cited by 70
The role of lamina cribrosa cells in optic nerve head fibrosis in glaucoma
Wallace, D., & O'Brien, C. J. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2014.12.006 · Cited by 71
“Several genes involved in the synthesis, maintenance and degradation of ECM are also regulated by HIF (Chi et al., 2006; Denko et al., 2003; Elvidge et al., 2006; Erler et al., 2006; Pollard et al., 2008) and hypoxia is thus likely to regulate ECM homoeostasis directly through the activity of HIF.”
BackgroundBoekhorst, V. T., Jiang, L., Mählen, M., Meerlo, M., Dunkel, G., Durst, F. C., Yang, Y., Levine, H., Burgering, B. M. T., & Friedl, P. (2021) · Current Biology · doi:10.1016/j.cub.2021.11.040 · Cited by 73
Augstein, A., Poitz, D. M., Braun-Dullaeus, R. C., Strasser, R. H., & Schmeißer, A. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0575-4 · Cited by 84
“This complex recognizes and binds to the hypoxia response element (HRE) [18], and thus induces a broad range of genes that are involved in multiple cellular processes like angiogenesis, glycolysis and cell survival, but also apoptosis [19, 20].”
BackgroundHypoxic Regulation of Gene Transcription and Chromatin: Cause and Effect
Kindrick, J. D., & Mole, D. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218320 · Cited by 71
Cellular oxygen sensing in health and disease
Mole, D. R., & Ratcliffe, P. J. (2008) · Pediatric Nephrology · doi:10.1007/s00467-007-0632-x · Cited by 80
“Despite evidence for disparate roles of HIF-1α and HIF-2α, the mechanisms regulating the abundance and activity of the two isoforms are largely concordant, and this is reflected in similar domain structures [13] (Fig.”
InfluentialSelf-citationOxygen tension plays a critical role in the hematopoietic microenvironment in vitro
Jing, D., Wobus, M., Poitz, D. M., Bornhäuser, M., Ehninger, G., & Ordemann, R. (2011) · Haematologica · doi:10.3324/haematol.2011.050815 · Cited by 71
“Although numerous studies have demonstrated increased SDF-1 levels under low oxygen conditions,(37;38) other reports do not suggest a significant modulation of SDF-1 in other cell types.(39;40) We found no in vitro SDF-1 induction in hypoxic MSC in this study.”
BackgroundEvensen, N. A., Li, Y., Kuscu, C., Liu, J., Cathcart, J. M., Banach, A., ZHANG, Q., Li, E., Joshi, S., Yang, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3978 · Cited by 67
Effect of chemical stabilizers of hypoxia-inducible factors on early lung development
Groenman, F. A., Rutter, M., Wang, J., Caniggia, I., Tibboel, D., & Post, M. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00486.2006 · Cited by 77
“CoCl2 is a strong inhibitor of FIH-1 but not PHDs (25).”
InfluentialBaek, J. H., Liu, Y. V., McDonald, K. R., Wesley, J. B., Hubbi, M. E., Byun, H., & Semenza, G. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703504200 · Cited by 66
Holden, V. I., Lenio, S., Kuick, R., Ramakrishnan, S. K., Shah, Y. M., & Bachman, M. A. (2014) · Infection and Immunity · doi:10.1128/iai.01849-14 · Cited by 62
“Stimulation with Ent induced nuclear stabilization of HIF-1 , similar to the stabilization of HIF-1 observed in response to DMOG (Fig.”
BackgroundInfluentialOxygen sensing and hypoxia-induced responses
Coleman, M. L., & Ratcliffe, P. J. (2007) · Essays in Biochemistry · doi:10.1042/bse0430001 · Cited by 65
Self-citationSatriotomo, I., Nichols, N. L., Dale, E. A., Emery, A. T., Dahlberg, J. M., & Mitchell, G. S. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.060 · Cited by 65
“Nanduri et al. (2009) demonstrated that HIF-1α was up-regulated and HIF-2α was down-regulated by chronic intermittent hypoxia.”
BackgroundInfluentialRole of Hypoxia in the Evolution and Development of the Cardiovascular System
Fisher, S. A., & Burggren, W. W. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1704 · Cited by 62
Lim, C. S., Qiao, X., Reslan, O. M., Xia, Y. Y., Raffetto, J. D., Paleolog, E. M., Davies, A. H., & Khalil, R. A. (2010) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2010.09.018 · Cited by 66
“Previous studies on hypoxia regulation of HIFsed a duration of about 16 hours to avoid the negative eedback mechanisms that may complicate the findings.(21) xamples of negative feedback mechanisms that can be ctivated by hypoxia include the generation of an antisense NA to HIF-1 (aHIF),(22) production of CBP/p300ntera…”
BackgroundHypoxia Regulates Alternative Splicing of HIF and non-HIF Target Genes
Sena, J. A., Wang, L., Heasley, L. E., & Hu, C. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0149 · Cited by 70
Liu, L., Zhao, X., Zou, H., Bai, R., Yang, K., & Tian, Z. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00420 · Cited by 66
“HIF-1 α or HIF-2 α subunits were suppressed using siRNAs (Elvidge et al., 2006).”
Hypoxia and Chromatin: A Focus on Transcriptional Repression Mechanisms
Batie, M., del Peso, L., & Rocha, S. (2018) · Biomedicines · doi:10.3390/biomedicines6020047 · Cited by 65
“Interestingly, knock-down of HIF isoforms prevents the majority of the effects of hypoxia on both gene induction and repression [12,105].”
BackgroundD’Amico, A. G., Maugeri, G., Reitano, R., Bucolo, C., Saccone, S., Drago, F., & D’Agata, V. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0621-7 · Cited by 62
“of many genes involved in different cellular mechanisms (Semenza et al. 1996; Kaelin and Ratcliffe 2008; Elvidge et al. 2006; Scheurer et al. 2004).”
BackgroundThe multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation
Strocchi, S., Reggiani, F., Gobbi, G., Ciarrocchi, A., & Sancisi, V. (2022) · Oncogene · doi:10.1038/s41388-022-02378-8 · Cited by 61
Hypoxia-regulated gene network in drug resistance and cancer progression
Lin, S.-C., Liao, W.-L., Lee, J., & Tsai, S. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214532755 · Cited by 61
Reactive oxygen species promote ovarian cancer progression via the HIF-1α/LOX/E-cadherin pathway
WANG, Y., Ma, J., SHEN, H., WANG, C., Sun, Y., Howell, S. B., & Lin, X. (2014) · Oncology Reports · doi:10.3892/or.2014.3448 · Cited by 63
Hypoxic regulation of the noncoding genome and NEAT1
Choudhry, H., & Mole, D. R. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv050 · Cited by 62
Niskanen, H., Tuszyńska, I., Zaborowski, R., Heinäniemi, M., Ylä‐Herttuala, S., Wilczyński, B., & Kaikkonen, M. U. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1214 · Cited by 62
“To assess CTCF binding in MCF-7 cells (19), closest features tool from BEDOPS software (20) was used to select CTCF peaks closest to hypoxia-inducible factor 1 alpha (HIF1 ) peaks (found in both HUVEC and MCF-7 datasets (21)) or TSS of hypoxia-regulated genes that were shared in HUVECs and MCF-7 cells (22).”
MethodRegulation of tissue perfusion in mammals by hypoxia‐inducible factor 1
Semenza, G. L. (2007) · Experimental Physiology · doi:10.1113/expphysiol.2006.036343 · Cited by 68
“Compared with HIF-1α:HIF-1β heterodimers, HIF2α:HIF-1β heterodimers transactivate an overlapping but distinct set of target genes (Elvidge et al. 2006).”
BackgroundOgawara, Y., Katsumoto, T., Aikawa, Y., Shima, Y., Kagiyama, Y., Soga, T., Matsunaga, H., Seki, T., Araki, K., & Kitabayashi, I. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2200 · Cited by 58
“GSEA revealed that, compared with control BM cells, the NI cells expressed significantly higher levels of a set of genes that are upregulated in NPMc AML (26), hypoxia (32), and myeloid development (33) (Figs 4I and 4J, Table S6).”
BackgroundMethodStantic, M., Sakil, H. A. M., Zirath, H., Fang, T., Sanz, G., Fernandez-Woodbridge, A., Marin, A., Susanto, E., Mak, T. W., Arsenian‐Henriksson, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421697112 · Cited by 58
“(A) GSEA was performed with two different gene sets: angiogenesis gene set (n = 21) (31) and hypoxia gene set (n = 171) (32).”
MethodPfeffer, I., Brewitz, L., Krojer, T. J., Jensen, S. A., Kochan, G. T., Kershaw, N. J., Hewitson, K. S., McNeill, L. A., Kramer, H., Münzel, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12711-7 · Cited by 60
Zhao, B., Liu, L., Mao, J., Zhang, Z., Wang, Q., & Li, Q. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0348-9 · Cited by 62
Rapamycin Rescues ABT-737 Efficacy in Small Cell Lung Cancer
Gardner, E. E., Connis, N., Poirier, J. T., Cope, L., Dobromilskaya, I., Gallia, G. L., Rudin, C. M., & Hann, C. L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3460 · Cited by 53
“To further illustrate the changes observed in HIF-1a transcripts, we plotted the log ratio of treatment groups (M) by the average intensity (A) for each probe in order to visualize how genome-wide transcriptional profiling data from the ABT-737–treated PDX models compared with a benchmark HIF-1a–regulated gene set (28…”
MethodHypoxia promotes liver stage malaria infection in primary human hepatocytes in vitro
Ng, S., March, S., Galstian, A., Hanson, K., Carvalho, T., Mota, M. M., & Bhatia, S. N. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.013490 · Cited by 54
“S6B) (Elvidge et al., 2006).”
Sridharan, V., Guichard, J., Li, C.-Y., Muise-Helmericks, R., Beeson, C. C., & Wright, G. L. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00466.2007 · Cited by 57
Ratcliffe, P. P., & Bishop, T. (2014) · Hypoxia · doi:10.2147/hp.s47598 · Cited by 62
Self-citationRole of Oxygen Availability in CFTR Expression and Function
Guimbellot, J. S., Fortenberry, J. A., Siegal, G. P., Moore, B. J., Wen, H., Venglarik, C. J., Chen, Y.-F., Oparil, S., Sorscher, E. J., & Hong, J. S. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0452oc · Cited by 58
“Gene expression patterns induced by hypoxia and by DMOG are known to be similar ( 32 ).”
The regulation of transcriptional repression in hypoxia
Cavadas, M. A. S., Cheong, A., & Taylor, C. T. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.02.024 · Cited by 60
Gao, W., Ferguson, G., Connell, P., Walshe, T. E., Murphy, R. P., Birney, Y. A., O'Brien, C. J., & Cahill, P. A. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.12.006 · Cited by 55
Mak, P., Chang, C., Pursell, B. M., & Mercurio, A. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221654110 · Cited by 62
Aumayr, K., Fathi, O., Traub‐Weidinger, T., Niederle, B., & Koperek, O. (2017) · Pathology & Oncology Research · doi:10.1007/s12253-017-0232-4 · Cited by 58
“[10, 43, 44] We could not show any significant correlation with slug or E-cadherin.”
Fandrey, J., Schödel, J., Eckardt, K., Katschinski, D. M., & Wenger, R. H. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-019-02334-8 · Cited by 60
“This finding was somewhat unexpected, since the numbers of genes being up- or downregulated, respectively, by HIF stabilization are similar [31].”
ResultTutzauer, J., Sjöström, M., Holmberg, E., Karlsson, P., Killander, F., Leeb-Lundberg, L. M. F., Malmström, P., Niméus, E., Fernö, M., & Jögi, A. (2022) · British Journal of Cancer · doi:10.1038/s41416-021-01630-4 · Cited by 53
“The signatures from Denko, Elvidge, Mense, and Sorensen were extracted from in vitro hypoxia (1% oxygen) treated human cells.”
MethodInfluentialHypoxia promotes production of neural crest cells in the embryonic head
Scully, D. M., Keane, E., Batt, E., Karunakaran, P., Higgins, D. F., & Itasaki, N. (2016) · Development · doi:10.1242/dev.131912 · Cited by 53
“The chemokine receptor Cxcr4 is also a HIF-1α-regulated gene involved in chemoattraction of neural crest cells to their destination (Barriga et al., 2013; Escot et al., 2013; Rezzoug et al., 2011; Staller et al., 2003).”
BackgroundIncreased activation of the hypoxia-inducible factor pathway in varicose veins
Lim, C. S., Kiriakidis, S., Paleolog, E. M., & Davies, A. H. (2012) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.10.111 · Cited by 56
Development of an in vitro renal epithelial disease state model for xenobiotic toxicity testing
Crean, D., Bellwon, P., Aschauer, L., Limonciel, A., Mönks, K., Hewitt, P. G., Schmidt, T., Herrgen, K., Dekant, W., Lukas, A., et al. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.11.015 · Cited by 53
Kwanghee, R., Park, C., & Lee, Y. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.119 · Cited by 56
“However, the gene expression profile data are in agreement with our data in that the ESR1 gene is indeed reduced in MCF-7 cells under hypoxic conditions, as determined by the Affymetrix microarray, supporting our observation of ESR1 repression [24].”
ResultNatsuizaka, M., Naganuma, S., Kagawa, S., Ohashi, S., Ahmadi, A., Subramanian, H. E., Chang, S., Nakagawa, K. J., Ji, X., Liebhaber, S. A., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-198598 · Cited by 55
“Hypoxia-mediated induction of IGFBP3 mRNA is impaired in HIF-1 / mouse embryonic stem cells (20) and cancer cells with HIF-1 knockdown (21), suggesting that HIF-1 might be a potential mediator of IGFBP3 induction.”
BackgroundHypoxia Correlates With Poor Survival and M2 Macrophage Infiltration in Colorectal Cancer
Qi, L., Chen, J., Yang, Y., & Hu, W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.566430 · Cited by 56
Hypoxia-induced invadopodia formation: a role for β-PIX
Hashim, N. F. M., Nicholas, N. S., Dart, A., Kiriakidis, S., Paleolog, E. M., & Wells, C. M. (2013) · Open Biology · doi:10.1098/rsob.120159 · Cited by 58
“DMOG is a pan-hydroxylase inhibitor that can not only inhibit the HIF prolyl hydroxylases, but also other hydroxylases [25]; and DMOG has been associated with non-HIF-1a-associated events [27].”
BackgroundNauta, T. D., van den Broek, M., Gibbs, S., van der Pouw-Kraan, T. C. T. M., Oudejans, C. B., van Hinsbergh, V. W. M., & Koolwijk, P. (2017) · Angiogenesis · doi:10.1007/s10456-016-9527-4 · Cited by 51
Hirsch, K., Taglauer, E. S., Seedorf, G., Callahan, C., Mandell, E. W., White, C. W., Kourembanas, S., & Abman, S. H. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0601oc · Cited by 55
Starmans, M. H. W., Chu, K. C., Haider, S., Nguyen, F., Seigneuric, R., Magagnin, M. G., Koritzinsky, M., Kasprzyk, A., Boutros, P. C., Wouters, B. G., et al. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.02.002 · Cited by 50
(2011) · Advances in cardiology · doi:10.1159/000325105 · Cited by 53
TRPC6 channels modulate the response of pancreatic stellate cells to hypoxia
Nielsen, N., Kondratska, K., Ruck, T., Hild, B., Kovalenko, I., Schimmelpfennig, S., Welzig, J., Sargin, S., Lindemann, O., Christian, S., et al. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-2057-0 · Cited by 50
“DMOG is an inhibitor prolyl-hydroxylases that are involved in the degradation of the hypoxia-inducible factor HIF [11].”
Lauer, V., Grampp, S., Platt, J. L., Lafleur, V. N., Lombardi, O., Choudhry, H., Kranz, F., Hartmann, A., Wullich, B., Yamamoto, A., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009827 · Cited by 54
Self-citationGarcia-Rojas, E. Y. L., Villanueva, C., & Bond, R. A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.709509 · Cited by 56
Lombardi, O., Li, R., Halim, S., Choudhry, H., Ratcliffe, P. J., & Mole, D. R. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111652 · Cited by 49
“Recent pan-genomic analyses of transcriptional regulation by hypoxia and binding of the HIF transcription factors to chromatin in cancer cell lines have highlighted the complexity of these responses, with many hundreds of genes under direct transcriptional regulation by HIF (Betts et al., 2013; Chi et al., 2006; Choud…”
BackgroundSelf-citationWierzbicki, P., Kłącz, J., Kotulak‐Chrząszcz, A., Wrońska, A., Stanisławowski, M., Rybarczyk, A., Ludziejewska, A., Kmieć, Z., & Matuszewski, M. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4830 · Cited by 60
“Although HIF1A and HIF2A represent different proteins, and they partially overlap in the activation of target genes; for example, the gene expression of C-X-C chemokine receptor type 4 (CXCR4) and solute carrier family 2 member 1 (SLC2A1) has been shown to be activated by either HIF1A or HIF2A (15).”
Targeting histone demethylase KDM5B for cancer treatment
Fu, Y.-D., Huang, M.-J., Guo, J., You, Y.-Z., Liu, H., Huang, L., & Yu, B. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112760 · Cited by 48
Zhang, N., & Walker, M. K. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-9007-6 · Cited by 52
“However, essentially all previous studies have focused on the interaction of hypoxia and AHR signaling when the AHR is activated by exogenous ligands, despite the fact that AHR regulates constitutive CYP1A1 expression in the absence of exogenous ligands [17, 18] and hypoxia alone can induce or repress CYP1A1 expressio…”
BackgroundYao‐Borengasser, A., Monzavi‐Karbassi, B., Hedges, R. A., Rogers, L. J., Kadlubar, S. A., & Kieber‐Emmons, T. (2015) · Oncology Reports · doi:10.3892/or.2015.3880 · Cited by 49
Koperek, O., Bergner, O., Pichlhöfer, B., Oberndorfer, F., Hainfellner, J. A., Kaserer, K., Horvat, R., Harris, A. L., Niederle, B., & Birner, P. (2011) · The Journal of Pathology · doi:10.1002/path.2926 · Cited by 47
“HIF regulates secretion or production of many factors that may be involved in stroma formation, such as fibronectin, TGFβ, collagens and enzymes crosslinking collagen, as well as metalloproteases and lysyloxidases [44].”
Background
Metadata
- Authors
- Elvidge, G. P., Glenny, L., Appelhoff, R. J., Ratcliffe, P. J., Ragoussis, J., & Gleadle, J. M.
- Affiliations
- University of Oxford (GB)
- Centre for Human Genetics (GB)
- Corresponding author
- Ragoussis, Jiannis
- Gleadle, Jonathan M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 281
- Issue
- 22
- Pages
- 15215-15226
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2011076742
- Cited by
- 464
- References
- 58
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 18 · 2023: 15 · 2022: 25 · 2021: 20 · 2020: 33 · 2019: 16 · 2018: 20 · 2017: 21 · 2016: 19 · 2015: 28 · 2014: 34 · 2013: 35 · 2012: 27
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5221 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
- Keywords
- hypoxia, 2-oxoglutarate-dependent dioxygenase, dimethyloxalylglycine, hypoxia-inducible factor, HIF-1α, HIF-2α, oxygen sensing, gene expression regulation, prolyl hydroxylation, PHD1, PHD2, PHD3, FIH-1, MCF-7 cells
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Amino Acids, Dicarboxylic, Cell Line, Enzyme Inhibitors, Gene Expression Regulation, Humans, Ketoglutarate Dehydrogenase Complex, RNA, Messenger, Transcription Factors, Cell Hypoxia, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, RNA, Small Interfering, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.